glp 1 trumprx GLP-1 Pricing Update: Savings and Compounded Options | Maggi Quinn, RHU, CHCC posted on the topic GLP-1 weight loss drugs will

Were changing the way the world treats weight

Recent Findings Many children and adolescents will likely benefit from GLP1-RA treatment for Binge Eating Disorder, Night Eating Syndrome, and Other Specified Eating or Feeding Disorder

While challenges with adherence, side effects, and weight regain upon discontinuation have prompted the search for additional strategies, targets like GLP-1R, GIPR, and GDF8 (Myostatin) still remain the most highly relevant and active areas of research for developing effective obesity treatments

The GLP-1 Receptor Agonist market size is expected to reach $18.32 billion in 2030 at a CAGR of 5.4%, driven by rising prevalence of diabetes.